To explore the association between tumor-infiltrating T lymphocyte populations with CRC prognosis, we determined the infiltration of CD3+, CD8+, or FoxP3+ T lymphocytes within the tumor, tumor margins, and in the normal adjacent tissue by immunohistochemistry. The gene discussed is CD8A; the disease is neoplasm.